Biochemical and clinical aspects of methotrexate neurotoxicity.
about
Methotrexate encephalopathy: Two cases in adult cancer patients, who recovered with pathophysiologically based therapy.Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophyEffects of early chemotherapeutic treatment on learning in adolescent mice: implications for cognitive impairment and remediation in childhood cancer survivorsLateral and dorsal column hyperintensity on magnetic resonance imaging in a patient with myelopathy associated with intrathecal chemotherapy.Population PK/PD model of homocysteine concentrations after high-dose methotrexate treatment in patients with acute lymphoblastic leukemia.Applications of a blood-brain barrier technology platform to predict CNS penetration of various chemotherapeutic agents. 2. Cationic peptide vectors for brain delivery.Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell TransplantationCentral neurotoxicity in cancer chemotherapy: pharmacogenetic insights.Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles.Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer.Temporal profiles of synaptic plasticity-related signals in adult mouse hippocampus with methotrexate treatment.Folate pathway polymorphisms predict deficits in attention and processing speed after childhood leukemia therapy.Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantationEnergy balance and fitness in adult survivors of childhood acute lymphoblastic leukemia.Methotrexate myelopathy after intrathecal chemotherapy: a case reportPolymorphisms in Genes Related to Oxidative Stress Are Associated With Inferior Cognitive Function After Therapy for Childhood Acute Lymphoblastic Leukemia.Homocysteine: exploring its potential as a pharmacodynamic biomarker of antifolate chemotherapy.Acute cardiac toxicity associated with high-dose intravenous methotrexate therapy: case report and review of the literature.Combined local blood-brain barrier opening and systemic methotrexate for the treatment of brain tumors.Case files of the New York City Poison Control Center: antidotal strategies for the management of methotrexate toxicity.Current treatment approaches to early childhood medulloblastoma.Depression and Insomnia in Patients With Psoriasis and Psoriatic Arthritis Taking Tumor Necrosis Factor AntagonistsMethotrexate induced leucoencephalopathy: A stroke mimic.Contribution of methotrexate in precipitation of manic episode in bipolar affective disorder explored: a case reportMethotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.Reduction-triggered breakable micelles of amphiphilic polyamide amine-g-polyethylene glycol for methotrexate delivery.Cognitive dysfunction and cancer: which consequences in terms of disease management?Concomitant rheumatoid arthritis and amyotrophic lateral sclerosis: report of two new cases and review of literature.Intra-CSF administration of chemotherapy medications.Convection-enhanced delivery of methotrexate-loaded maghemite nanoparticles.Neurotoxicity after high-dose methotrexate (MTX) is adequately explained by insufficient folinic acid rescue.Intrathecal Methotrexate-Induced Posterior Reversible Encephalopathy Syndrome (PRES).The in vitro and in vivo anti-tumor effects of MTX-Fe3O 4-PLLA-PEG-PLLA microspheres prepared by suspension-enhanced dispersion by supercritical CO2.Influence of ADORA2A gene polymorphism on leukoencephalopathy risk in MTX-treated pediatric patients affected by hematological malignancies.Diffusion and perfusion imaging in subacute neurotoxicity following high-dose intravenous methotrexate.Stroke-like encephalopathy following high-dose intravenous methotrexate in an adolescent with osteosarcoma: a case report.Clinical reasoning: progressive visuospatial problems in a 71-year-old manMethotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge and Response to Aminophylline.Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution.The effect of repeated administration of methotrexate (MTX) on rat ovary: measurement of serum antimullerian hormone (AMH) levels.
P2860
Q30252387-59ABB4E0-82CC-4D6D-AFD3-C185701DFD27Q30492560-C5D44C0F-407E-4F21-9326-B51F367A6AABQ30540341-7A2EFED8-B323-485E-8331-437B9D7F1CD1Q30656549-EE9F2767-6F9D-44B7-ABD5-D505CB902F46Q31103489-8C15FE40-D1B6-4678-BA8B-9F0736B963C6Q33268142-26C0EAC4-2501-4E79-9AA4-F0A86047696FQ33679931-F10F07FD-AE8B-48E6-BC0D-DAA639CC5A75Q33857581-5E4A5D79-B6E9-4DA1-A87F-FAEDF66B2355Q33931249-B01DDD9B-B1B9-46C7-B024-B844A9B5BAD0Q34815323-C6F90E0C-9338-4228-9A8F-73FA67E514F1Q35020774-5BEA2EE3-21BD-4D49-8242-C066987E8E03Q35098712-0DF4D06E-A69F-4694-9A13-69AF4A730B24Q35136510-B1AE763C-86D0-47FD-A079-9F0884E639BBQ35661991-95818E21-C489-4CA3-8E26-D4E236F28383Q35750949-FE4414A4-8ED1-492C-BDC9-745A107184EBQ35771188-B5708871-80AF-44B8-8E5C-B651855EF574Q35976422-74E51A3E-7D94-4AF8-A5A2-008673642EAAQ36257973-3BE25566-E0A5-4D3D-A83B-8CF298C813B6Q36267243-5D390DA1-5D41-42F9-B5F2-BCEF71CCF390Q36548685-5504F2FD-FEF7-468A-9E66-8C22A7309A65Q36558688-257EAEF0-ADE8-4788-82E0-9AA24E9C3F62Q36988833-2ED2E1BA-0B8A-415C-9737-C3B1E1495193Q37210427-FB39A339-DC03-4201-8F25-2CE21EFD0FADQ37248070-C11691BE-F9E6-4C24-8048-E6378C16AA18Q37627699-6348EB61-4320-40AE-BED9-C5163A91A539Q37733291-65B83982-2A3E-42AB-A4F9-CB4D7F42F33EQ37831271-442A78C4-5594-4B32-81E1-9CE09ED6E160Q37831814-6BEDC2BD-B973-48EC-B32C-CFD3966E86BFQ38015719-E5281C96-EF12-4C06-ACE6-1232B9E7AE24Q38257849-517B9B4C-F014-40D2-B26E-1BA647D99364Q38813392-C919DB73-340A-4C68-8B14-B453D50A1386Q38914391-04517674-6B5B-409C-BC03-E75A3E81EF83Q38984024-8AD316FE-45A5-4CD0-A96F-FE2A59AB6C7EQ39615014-3D70E612-52B0-478C-B7C9-77B347F88E84Q41787986-69AFFDE1-CF28-45FA-A6AF-6CA998681A4FQ41878956-69A4B731-7D7A-4A6E-B503-55D22DC1BDF1Q42754048-FF8612D9-74A6-4261-B20F-FDA7A4EBF56DQ42938463-4F840ADE-BE44-44C5-82DE-F266929512E2Q43063275-EE76C7B7-A743-4595-AC33-DF1A6BD69D80Q44308980-4F26721E-05CA-4B33-B4B8-A623991A3F09
P2860
Biochemical and clinical aspects of methotrexate neurotoxicity.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Biochemical and clinical aspects of methotrexate neurotoxicity.
@ast
Biochemical and clinical aspects of methotrexate neurotoxicity.
@en
type
label
Biochemical and clinical aspects of methotrexate neurotoxicity.
@ast
Biochemical and clinical aspects of methotrexate neurotoxicity.
@en
prefLabel
Biochemical and clinical aspects of methotrexate neurotoxicity.
@ast
Biochemical and clinical aspects of methotrexate neurotoxicity.
@en
P2093
P356
P1433
P1476
Biochemical and clinical aspects of methotrexate neurotoxicity.
@en
P2093
Achim Becker
Sandra Vezmar
Ulrich Jaehde
P304
P356
10.1159/000069773
P577
2003-05-01T00:00:00Z